Brings more than 25 years of biopharma business development and corporate strategy expertiseBOTHELL, Wash., Feb. 03, 2026 (GLOBE NEWSWIRE) -- LeonaBio, Inc. (NASDAQ: LONA), a clinical-stage ...

Most organizations struggle to innovate because they don’t solve the gap between a compelling strategy and consistent ...

Initiation of the IIMPACT study follows promising Phase 1 results where Restem-L demonstrated clinically meaningful efficacy ...

Collaboration reinforces regulatory diligence, nonclinical strategy and clinical trial integrity for novel intranasal concussion therapy ...

The crypto market is witnessing another sharp shift in market sentiment as MicroStrategy’s balance sheet, which is heavily ...

In a significant leadership development within the UAE’s higher education sector, Dr Richa Arora, an award-winning global ...

The US-India Strategic Partnership Forum has hailed the Union Budget 2026–27 as a progressive, investment-friendly roadmap that enhances India’s competitiveness, supports global capital inflows, and ...

Clinical progress, pipeline expansion, and operational momentum underpin leadership continuity as the Company advances into 2026 and beyond SEATTLE, WA / ACCESS Newswire / February 3, 2026 / Aptevo Th ...

Hardware development rewards humility, discipline and clear thinking. The lessons above are rarely learned quickly, and never cheaply. But teams that internalize them gain something powerful: the ...

The RTA signs deal with The Boring Company to begin Dubai Loop, a high-tech passenger tunnel linking DIFC and Dubai Mall ...

Dr. Stacy Lindborg is president and CEO of IMUNON, a clinical-stage company in phase 3 development with a lead DNA-mediated immunotherapy for advanced ovarian cancer. Dr. Lindborg has worked in the ...

VANCOUVER, BC / ACCESS Newswire / February 3, 2026 / Lobe Sciences Ltd. (CSE:LOBE)(OTCQB:LOBEF)(Frankfurt:LOBE.F) ("Lobe" or the "Company"), a biopharmaceutical company advancing programs in diseases ...